-
Oberoi Realty
1,751.00 1,440.05(%) -
Canara Bank
106.35 78.58(%) -
SpiceJet
40.84 79.90(%) -
Lodha Developers
1,330.55 1,036.00(%) -
Havells India
1,549.05 1,360.05(%) -
ICICI Bank
1,489.95 1,482.00(%) -
One 97
1,090.00 1,063.00(%) -
Bombay Dyeing
190.85 256.25(%) -
Ola Electric
43.95 157.53(%) -
Dixon Technolog.
16,671.15 19,149.80(%) -
Anthem Bioscienc
765.00 752.50(%) -
Eternal Ltd
303.60 311.60(%) -
Paradeep Phosph.
205.60 193.15(%) -
Pidilite Inds.
2,900.75 2,620.15(%) -
Reliance Industr
1,426.90 1,551.00(%) -
I R F C
136.90 209.10(%) -
St Bk of India
825.00 895.30(%) -
Waaree Energies
3,199.00 3,740.75(%) -
Jayaswal Neco
43.10 55.34(%) -
Tata Motors
692.95 1,179.05(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Divis Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs
- Indian Private
- BSE Code : 21188.0
- ISIN : INE361B01024
-
Today’s Low
6,579.50 -
Today’s High
6,685.00

-
Open
6,685.00 -
Perv Close
6,688.00 -
52W Low
4,395.30 -
52W High
7,071.50
Key Indicators
-
P/E(TTM)
79.48
-
Mar.Cap (₹Cr.)
175,554.37
-
Div & Yield %
0.45
-
Book Value(₹)
561.09
-
Debt-Equity Ratio
-1.12
-
AGM Date
22-Jul-2025
-
EPS
83.18
-
P/E Ratio
79.48
Financials Ratios
-
Debt-Equity Ratio
0.00
-
Mar.Cap (₹Cr.)
175,554.37
-
RONW (%)
12.15
-
ROCE (%)
16.41
Score Board
-
Equity (₹ in Cr.)
53.09
-
BV (₹)
561.10
-
Sales( ₹ in Cr.)
9,198.00
-
NP (in Cr.)
2,208.27
-
NP Var(%)
40.0
-
Div%
1500.0
-
CPS (₹)
98.30
-
EPS (₹)
83.20
-
Traded Value (₹ in Lakhs)
175,509.24
-
52 Week High
7,071.50
-
52 Week Low
4,395.30
-
Price BSE
6611.0
-
Price NSE
6,613.00
-
Market Capital( in Cr.)
175,509.24
-
P/C Ratio
67.30
-
P/E Ratio
79.50
-
Price Vs.BV
83.20
-
11-Jun-2025( 01:05)
Hot Pursuit - Divis... - <p>Divis Laboratories Ltd is u...
-
02-Jun-2025( 01:35)
Hot Pursuit - Divis... - <p>Divis Laboratories Ltd is d...
-
24-May-2025( 10:06)
Hot Pursuit - Divis... - As part of the agreement, Divi...
-
24-May-2025( 11:34)
Corporate News - Divis... - Divis Laboratories has entered...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 9,198.00 | 7,665.00 | 7,625.00 | 8,879.82 | 6,798.61 | 5,310.57 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 9,198.00 | 7,665.00 | 7,625.00 | 8,879.82 | 6,798.61 | 5,310.57 |
Other Income | 352.00 | 337.00 | 349.00 | 111.26 | 62.53 | 189.86 |
Stock Adjustments | 83.00 | 127.00 | -50.00 | 449.99 | 100.00 | 94.10 |
Total Income | 9,633.00 | 8,129.00 | 7,924.00 | 9,441.07 | 6,961.14 | 5,594.53 |
EXPENDITURE : | ||||||
Raw Materials | 3,827.00 | 3,270.00 | 3,035.00 | 3,499.18 | 2,416.47 | 2,223.95 |
Power and Fuel Cost | 465.00 | 477.00 | 496.00 | 390.05 | 319.15 | 280.73 |
Employee Cost | 1,210.00 | 1,067.00 | 953.00 | 926.55 | 808.68 | 608.36 |
Other Manufacturing Expenses | 276.00 | 299.00 | 285.00 | 255.38 | 202.29 | 184.36 |
Selling and Administration Expenses | 449.00 | 367.00 | 402.00 | 340.16 | 292.53 | 222.86 |
Miscellaneous Expenses | 74.00 | 137.00 | 55.00 | 40.95 | 37.69 | 68.00 |
Employee Benefit Expenses | 1,210.00 | 1,067.00 | 953.00 | 926.55 | 808.68 | 608.36 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 6,301.00 | 5,617.00 | 5,226.00 | 5,452.27 | 4,076.81 | 3,588.26 |
Operating Profit | 3,332.00 | 2,512.00 | 2,698.00 | 3,988.80 | 2,884.33 | 2,006.27 |
Interest | 2.00 | 4.00 | 2.00 | 1.73 | 1.81 | 7.03 |
Gross Profit | 3,330.00 | 2,508.00 | 2,696.00 | 3,987.07 | 2,882.52 | 1,999.24 |
Depreciation | 401.00 | 376.00 | 342.00 | 310.55 | 254.65 | 185.95 |
Profit Before Tax | 2,929.00 | 2,132.00 | 2,354.00 | 3,676.52 | 2,627.87 | 1,813.29 |
Current Tax | 793.00 | 511.00 | 438.00 | 637.20 | 609.05 | 387.79 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | -73.00 | 45.00 | 108.00 | 90.78 | 64.10 | 52.79 |
Reported Net Profit | 2,209.00 | 1,576.00 | 1,808.00 | 2,948.54 | 1,954.72 | 1,372.71 |
Extraordinary Items | 0.73 | 0.74 | 3.07 | -1.65 | -2.45 | 41.46 |
Adjusted Net Profit | 2,208.27 | 1,575.26 | 1,804.93 | 2,950.19 | 1,957.17 | 1,331.25 |
Adjustment below Net Profit | -2.00 | -1.00 | 2.00 | 2.18 | 0.16 | -92.52 |
P & L Balance brought forward | 11,725.00 | 10,922.00 | 9,967.00 | 7,588.31 | 5,814.44 | 5,636.87 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 575.00 | 772.00 | 855.00 | 571.50 | 181.01 | 1,102.62 |
P & L Balance carried down | 13,357.00 | 11,725.00 | 10,922.00 | 9,967.53 | 7,588.31 | 5,814.44 |
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 424.75 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 1,500.00 | 1,500.00 | 1,500.00 | 1,500.00 | 1,000.00 | 800.00 |
Dividend Per Share(Rs) | 30.00 | 30.00 | 30.00 | 30.00 | 20.00 | 16.00 |
Earnings Per Share-Unit Curr | 83.36 | 59.47 | 68.23 | 111.08 | 73.64 | 51.71 |
Earnings Per Share(Adj)-Unit Curr | 83.36 | 59.47 | 68.23 | 111.08 | 73.64 | 51.71 |
Book Value | 562.08 | 508.83 | 479.43 | 440.44 | 349.28 | 275.63 |
Book Value(Adj)-Unit Curr | 562.08 | 508.83 | 479.43 | 440.44 | 349.28 | 275.63 |